发明名称 |
ANTI-CD19 ANTIBODY HAVING ADCC AND CDC FUNCTIONS AND IMPROVED GLYCOSYLATION PROFILE |
摘要 |
The present invention relates to an anti-CD19 antibody having a variant Fc region having some specific amino acid modifications relative to a wild-type Fc region which confer one or several useful effector functions. The present invention relates in particular to chimeric, humanized or full human anti-CD19 antibodies comprising such a variant Fc region. It relates advantageously to antibodies with an interesting and valuable glycosylation profile, especially a low fucose level and/or a high oligomannose level and low level of sialylated glycoform. The present invention also relates to the use of these antibodies in the treatment, prevention or management of disease or disorder, such as cancer, especially a B-cell malignancy, and auto-immune disease. |
申请公布号 |
WO2012010562(A1) |
申请公布日期 |
2012.01.26 |
申请号 |
WO2011EP62271 |
申请日期 |
2011.07.18 |
申请人 |
INTERNATIONAL - DRUG - DEVELOPMENT - BIOTECH;VERMOT-DESROCHES, CLAUDINE;VUILLERMOZ, BORIS SEBASTIEN |
发明人 |
VERMOT-DESROCHES, CLAUDINE;VUILLERMOZ, BORIS SEBASTIEN |
分类号 |
A61K47/48;C07K16/28 |
主分类号 |
A61K47/48 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|